0001179110-20-004927.txt : 20200417
0001179110-20-004927.hdr.sgml : 20200417
20200417160223
ACCESSION NUMBER: 0001179110-20-004927
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200416
FILED AS OF DATE: 20200417
DATE AS OF CHANGE: 20200417
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDSTEIN MICHAEL
CENTRAL INDEX KEY: 0001043027
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37477
FILM NUMBER: 20799674
MAIL ADDRESS:
STREET 1: 3 EAST 84 STREET
CITY: NEW YORK
STATE: NY
ZIP: 10028
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teladoc Health, Inc.
CENTRAL INDEX KEY: 0001477449
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 043705970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
BUSINESS PHONE: 2036352002
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: Teladoc, Inc.
DATE OF NAME CHANGE: 20091123
4
1
edgar.xml
FORM 4 -
X0306
4
2020-04-16
0
0001477449
Teladoc Health, Inc.
TDOC
0001043027
GOLDSTEIN MICHAEL
C/O TELADOC HEALTH, INC.,
2 MANHATTANVILLE ROAD, SUITE 203
PURCHASE
NY
10577
1
0
0
0
Common Stock
2020-04-16
4
M
0
13105
8.71
A
14023
D
Common Stock
2020-04-16
4
M
0
1700
16.64
A
15723
D
Common Stock
2020-04-16
4
S
0
918
165.93
D
14805
D
Common Stock
2020-04-16
4
S
0
14805
169.13
D
0
D
Stock Option (right to buy)
8.71
2020-04-16
4
M
0
13105
0.00
D
2025-02-25
Common Stock
13105
0
D
Stock Option (right to buy)
16.64
2020-04-16
4
M
0
1700
0.00
D
2026-08-08
Common Stock
1700
8000
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on February 29, 2020.
Represents the weighted average price of transactions ranging from $166.00 to $171.06. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
The option vested as to 25% of the shares on February 25, 2016. The remainder of the shares vested in 36 equal monthly installments thereafter.
The option vested in full on May 24, 2017.
/s/ Adam C. Vandervoort, attorney-in-fact
2020-04-17